Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Oxaliplatin × CNS × Clear all

Phase

Status

Completed 6 Unknown 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 118 Lymphoid 8 Thoracic 6 Gynecologic 6 Breast 6 Head & Neck 3 Tumor-Agnostic 2 Other solid neoplasm 2 Other hematologic neoplasm 2 Sarcoma 1 Plasma cell 1 NET 1 Myeloid 1 Genitourinary 1 Endocrine 1 Dermatologic 1 Classical hematology 1 CNS 1

Conditions

Neuroblastoma 1

Interventions

Temozolomide 68 Radiotherapy 34 Bevacizumab 31 Radiosurgery 17 Magnetic Resonance Spectroscopy 15 Cyclophosphamide 14 Irinotecan 13 Radiation 12 Carboplatin 11 Topotecan 10 Nivolumab 9 Filgrastim 9 Etoposide 9 pembrolizumab 8 Radiotherapy, Intensity-Modulated 8 Lomustine 7 Granulocyte Colony-Stimulating Factor 7 Everolimus 7 Erlotinib Hydrochloride 7 Mental Status and Dementia Tests 6 Melphalan 6 Ipilimumab 6 Imatinib Mesylate 6 poly ICLC 5 fludarabine phosphate 5 fludarabine 5 antineoplaston AS 2-1 5 antineoplaston A10 5 Vincristine 5 Panobinostat 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02630043 2024-08-06

Trial of Tolcapone With Oxaliplatin for Neuroblastoma

Milton S. Hershey Medical Center

Phase 1 Terminated

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡